[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336374-105":59,"doc-detail-336374-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","internal-validation-of-automated-visual-evaluation-ave-on-smartphone-images-for-cervical-cancer-screening-in-a-prospective-study-in-zambia","Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia","","Objectives: Visual inspection with acetic acid (VIA) is widely used for cervical cancer screening, yet remains subjective and dependent on sustained training and quality assurance. This study developed, trained, and validated an artificial-intelligence-based “Automated Visual Evaluation” (AVE) tool for smartphone-captured cervix images to identify precancerous lesions. Design: Prospective study in eight public health facilities in Zambia. Participants: 8204 women aged 25–55. AVE’s performance for detecting CIN2+ showed high accuracy with an AUC of 0.91.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/internal-validation-of-automated-visual-evaluation-ave-on-smartphone-images-for-cervical-cancer-screening-in-a-prospective-study-in-zambia/336374/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/internal-validation-of-automated-visual-evaluation-ave-on-smartphone-images-for-cervical-cancer-screening-in-a-prospective-study-in-zambia/336374.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the AVE tool in this study?","Question",{"text":112,"@type":113},"The AVE tool is designed to assess smartphone-captured cervix images and identify precancerous lesions, aiming to augment the performance of VIA.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the AVE algorithm evaluated?",{"text":117,"@type":113},"It was evaluated in a prospective study using performance metrics including AUC, sensitivity, and specificity, with images matched to clinical information and histopathology when applicable.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main performance results for detecting CIN2+?",{"text":121,"@type":113},"For general population screening, AVE achieved an AUC of 0.91, with sensitivity of 85% and specificity of 86% based on maximizing Youden’s index.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336374,1790999011,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","DOI: 10. 1002/cam4 .7355  \nRESEAR CH ARTICLE  \nInternal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia  \nLiming Hu1  | Mulindi H. Mwanahamuntu2 | VikrantV. Sahasrabuddhe3 | Caroline Barrett4 | Matthew P. Horning1 | Ishan Shah1 | Zohreh Laverriere1 | Dipayan Banik1 | Ye Ji1 | Aaron Lunda Shibemba2 | Samson Chisele2 | Mukatimui Kalima Munalula2 | Friday Kaunga2 | Francis Musonda2 |  \nEvans Malyangu2 | Karen Milch Hariharan4 | Groesbeck P. Parham2,5  \n1Global Health Labs, Inc., Bellevue, Washington, USA  \n2University Teaching Hospital, Lusaka, Zambia  \n3National Cancer Institute, NIH, Bethesda, Maryland, USA  \n4Clinton Health Access Initiative (CHAI), Inc.,, Boston, Massachusetts, USA  \n5University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA  \nCorrespondence  \nLiming Hu, Global Health Labs, Inc., Bellevue, WA, USA. [Email:](Email: dawninghu@gmail.com)[ dawninghu@gmail.com](Email: dawninghu@gmail.com)  \nFunding information  \nUS National Cancer Institute, Grant/ Award Number: UH3CA202721; Global Health Labs, Inc ([www.ghlabs.org](www.ghlabs.org)); Unitaid  \nAbstract  \nObjectives: Visual inspection with acetic acid (VIA) is a low-cost approach for cervical cancer screening used inmost low-and middle-income countries (LMICs) but, similar to other visual tests, is subjective and requires sustained training and quality assurance. We developed, trained, and validated an artificial-intelligencebased “Automated Visual Evaluation”(AVE) tool that can be adapted to run on smartphones to assess smartphone-captured images of the cervix and identify precancerous lesions, helping augment VIA performance.  \nDesign: Prospective study.  \nSetting: Eight public health facilities in Zambia.  \nParticipants: A total of 8204 women aged 25–55.  \nInterventions: Cervical images captured on commonly used low-cost smartphone models were matched with key clinical information including human immunodeficiency virus (HIV) and human papillomavirus (HPV) status, plus histopathology analysis (where applicable), to develop and train an AVE algorithm and evaluate its performance for use as a primary screen and triage test for women who are HPV positive.  \nMain Outcome Measures: Area under the receiver operating curve (AUC); sensitivity; specificity.  \nResults: As a general population screening tool for cervical precancerous lesions, AVE identified cases of cervical precancerous and cancerous (CIN2+) lesions with high performance (AUC = 0.91, 95% confidence interval [CI] = 0.89–0.93), which translates to a sensitivity of 85%(95% CI = 81%–90%) and specificity of 86%(95% CI = 84%–88%) based on maximizing the Youden's index. This represents a considerable improvement over naked eye VIA, which as per a meta-analysis by  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine. 2024;13:e7355 .  \n[https://doi.org/10.1002/cam4.7355](https://doi.org/10.1002/cam4.7355)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 10  \nthe World Health Organization (WHO) has a sensitivity of 66% and specificity of 87%. For women living with HIV, the AUC ofAVE was 0.91 (95% CI = 0.88–0.93), and among those testing positive for high-risk HPV types, theAUC was 0.87 (95% CI = 0.83–0.91) .  \nConclusions: These results demonstrate the feasibility of utilizing AVE on images captured using a commonly available smartphone by nurses in a screening program, and support our ongoing efforts for moving to more broadly evaluate AVE for its clinical sensitivity, specificity, feasibility, and acceptability across a wider range of settings. Limitations of this study include potential inflation of performance estimates due to verifica","cbCaicTEJyZTd0ly","https://ap.wps.com/l/cbCaicTEJyZTd0ly","pdf",549270,"English","# Abstract\n## Objectives and design\n## Setting and participants\n## Interventions and outcomes\n## Results and conclusions","[{\"question\":\"What is the purpose of the AVE tool in this study?\",\"answer\":\"The AVE tool is designed to assess smartphone-captured cervix images and identify precancerous lesions, aiming to augment the performance of VIA.\"},{\"question\":\"How was the AVE algorithm evaluated?\",\"answer\":\"It was evaluated in a prospective study using performance metrics including AUC, sensitivity, and specificity, with images matched to clinical information and histopathology when applicable.\"},{\"question\":\"What were the main performance results for detecting CIN2+?\",\"answer\":\"For general population screening, AVE achieved an AUC of 0.91, with sensitivity of 85% and specificity of 86% based on maximizing Youden’s index.\"}]","Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia | PDF",1790014756,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d31811414d499dc6cb32b0cb87e41a2c.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e729c16143a6a5b439058ca777ee753e.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5aa8b3b2fd90e288c42709b74a380ea5.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a697e040e48c542a847a26a22d77f132.webp",980,1287]